DESIGN, SYNTHESIS AND ANTIBACTERIAL EVALUATION OF 1-[(1R,2S)-2-FLUOROCYCLOPROPYL] CIPROFLOXACIN-(4-METHYL-3-ARYL)-1,2,4-TRIAZOLE-5(4H)-THIONE HYBRIDS

Fourteen novel 1-[(1R,2S)-2-Fluorocyclopropyl] ciprofloxac in-(4-methyl-3-aryl)-1,2,4-triazole-5(4H)-thione hybrids 6a-n were designed, synthesized and assessed for their in vitro antibacterial activities against representative Gram-positive and Gram-negative bacteria. All hybrids 6a-n exhibited promising antibacterial activity, especially against Gram-negative pathogens, warrant further investigation.